Replies to post #227649 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Dilutions come with the territory. An investor complaining biotech is volatile is like a fish complaining water is wet.

With $3.3M cash in hand, Leo should be done selling to Aspire this quarter. Now we wait for P result. With B-OM data completed yesterday, final negotiations can start. Competitions give leverage to IPIX. From the 10-Q,

“The results have attracted inquiries, additional confidential disclosure agreements, and discussions with pharmaceutical companies."